GlassScriptPhysician profile
Thomas Skinner
NPI 1144620113
$5,842.82
in general payments reported to CMS, 2019-2025
24 companies · $933 in 2025
The $933 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,680 · 2022: $1,055 · 2023: $1,278 · 2024: $896 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,107.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $743.64 | 2021-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $645.64 | 2021-2025 | Repatha, Repatha |
| Inari Medical, INC. | $625.67 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $528.22 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $375.71 | 2021-2023 | Farxiga |
| Cvrx, INC. | $321.91 | 2023 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $301.99 | 2023-2025 | Uptravi, Opsumit |
| Pfizer INC. | $287.08 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $274.87 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $243.98 | 2022-2023 | Optimizer |
| Sanofi-Aventis U.S. LLC | $207.21 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.77 | 2022-2025 | Jardiance |
| Medtronic, INC. | $183.41 | 2022-2024 | Symplicity G3, Mosaic |
| Janssen Pharmaceuticals, INC | $166.00 | 2021-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $136.49 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $130.35 | 2023 | Tandemlife |
| Vital Connect, INC | $111.61 | 2025 | Vitalpatch Rtm |
| Silk Road Medical, INC. | $108.57 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Irhythm Technologies, INC. | $77.71 | 2021-2023 | Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $76.55 | 2021-2025 | Eliquis, Camzyos |
| United Therapeutics Corporation | $47.32 | 2024-2025 | Tyvaso, Remodulin, Orenitram |
| Sobi, INC | $29.86 | 2021 | |
| Merck Sharp & Dohme LLC | $16.53 | 2023 | Verquvo |
| Scpharmaceuticals INC. | $13.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Skinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.